Dr. Douglas R Galasko MD
Neurologist | Neurology
9350 Campus Point Dr Perlman Ambulatory C La Jolla CA, 92037About
Dr. Douglas Galasko is a distinguished Neurologist in La Jolla, CA. Dr. Galasko specializes in diagnosing, treating, and managing disorders of the brain and nervous system. With expertise in handling complex conditions like epilepsy, multiple sclerosis, and migraines, Dr. Galasko employs advanced techniques and personalized treatment plans to improve patient outcomes. As a neurologist, Dr. Galasko is committed to staying abreast of the latest developments in neurological research and therapies.
Education and Training
University of Witwatersrand, School of Medicine, South Africa Medical Degree
UC San Diego, School of Medicine, San Diego, CA Other Degree
Professor of Neurosciences Medical Degree
Johns Hopkins School of Medicine, Baltimore, MD Other Degree
Board Certification
Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyABPN
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Measuring cognitive change in a cohort of patients with Alzheimer's disease.
- Part V. Genetic advances and biological markers for Alzheimer's disease.
- Extrapyramidal signs and cognitive abilities in Alzheimer's disease.
- Neuromotor abnormalities and risk for psychosis in Alzheimer's disease.
- Quantifying drug-induced changes in parkinsonian rigidity using an instrumental measure of activated stiffness.
- Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.
- Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia.
- Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam.
- Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson's disease with dementia.
- Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates.
- Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.
- Fractional synthesis and clearance rates for amyloid β.
- Degree of bilingualism predicts age of diagnosis of Alzheimer's disease in low-education but not in highly educated Hispanics.
- Improved statistical power of Alzheimer clinical trials by item-response theory: proof of concept by application to the activities of daily living scale.
- Antioxidants for Alzheimer disease-reply.
Clinical Trials
Dr. Douglas R Galasko MD's Practice location
San Diego, CA 92103Get Direction
Dr. Douglas R Galasko MD's reviews
Write ReviewPatient Experience with Dr. Galasko
Recommended Articles
- An Orlando Couple’s Efforts Towards Parkinson’s Disease Awareness
Parkinson’s Disease, the degenerative disorder which affects the patient’s central nervous system — specifically, the motor system —, is a condition which affects millions of persons from around the world. As of 2015, over 6 million individuals suffer from this condition, with 117,400...
- Parkinson's Disease Can Appear Up to 10 Years Before Diagnosis
Parkinson’s disease is a long-term neurological disorder that mainly affects the body’s movements. This disorder attacks the muscle control; therefore, involuntary movements of a Parkinson’s disease patient are very evident. Most patients have a hard time controlling their balance and movement...
- Parkinson's: Tips From a Professional Occupational Therapist
Once the diagnosis of Parkinson's has been dropped on a person, it is natural to feel devastated. Modern medicine can help a lot but still, it cannot stop the progression of the disease. However, with lifestyle changes a person can delay the progression of symptoms, and continue to live...
- Drug Exondys 51 Helps to Preserve Lung Function in Duchenne
Duchenne muscular dystrophy is a rare genetic condition that affects one in 3500-5000 male children. It is a condition in which the muscles fail to produce enough dystrophin due to a genetic defect; dystrophin is essential to protect muscles from wear and tear. The deficit of dystrophin causes...
- Low Adherence to Antidepressants May Increase Mortality in Parkinson's Patients
Parkinson’s disease, a neurological condition that affects a person’s body movements, has been affecting thousands of people’s physical and mental abilities. According to the National Parkinson Foundation, Parkinson’s disease itself is not fatal. However, complications that are brought by...
- Why We Should Not Define Autism in Terms of ‘Deficits’
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects communication and behavior. It is characterized by challenges with communication, social interaction, and repetitive behaviors. These challenges involve impairments in social reciprocity and in the use of verbal and...
Nearby Providers
- Dr. Amirhassan Bahreman M.D.8851 Center Dr La Mesa CA 91942
- Dr. Ross M. Mandeville MD7629 Girard Ave La Jolla CA 92037
- Wade H.M. Wong MD9300 CAMPUS POINT DR LA JOLLA CA 92037
- Dr. Monali S. Patel M.D.6645 Alvarado Road San Diego California 92120
- Mrs. Galina Vladimirovna Nikolskaya M.D.200 W ARBOR DR SAN DIEGO CA 92103
- Dr. Kristi Ann Dove MD4094 4TH AVE SAN DIEGO CA 92103